4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001209191-21-068850
Options or other derivatives
- Chief Executive Officer acquired 920,312 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hansen Carl L. G. Chief Executive Officer | 2021-12-07 | Grant or award · Share Option (right to buy) | +920,312 | 5,913,122 | D | ||
Loading xslF345X03/doc4.xml…